Expert Analysis

Managing HCC and Liver Transplantation

Source: CCO Independent Conference Coverage of the 2005 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Managing HCC and Liver Transplantation

Faculty:

Norah Terrault, MD, MPH
Paul Martin, MD
Robert J. Fontana, MD

CREDIT INFORMATION

Release Date: January 27, 2006

Expiration Date: January 26, 2007

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.6 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Review the latest approaches to diagnosis and monitoring of HCC.
Discuss the advantages and disadvantages of different types of liver transplantation.
Describe various strategies for treating patients with HCC in order to improve their options for liver transplantation.

Topics covered include:

HCC Prevention
Benefits of Screening for HCC
Interferon after Curative Resection
Pretransplant RFA to Meet the Milan Criteria
Pretransplant TACE to Meet the Milan Criteria
Living Donor vs Deceased Donor Liver Transplantation
Impact of Transplant Center Experience on Outcomes of Living Donor Transplantation
Outcomes of Liver Transplantation From Nonheart-Beating Deceased Donors

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.